Dong Xie

15PUBLICATIONS
10CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 03, 2024
Surgical resection due to poor outcome of the immunotherapy of a relapsed mediastinal liposarcoma: a case report.

Ming-Ji Wang, Shu-Quan Xu, Lei-Lei Wu

|Mar 28, 2024
Neoadjuvant chemoimmunotherapy confers survival advantage for patients undergoing sleeve lobectomy.

Tao Chen, Jialiang Wen, Yiming He

|Mar 01, 2024
Validation of the 9th edition of the TNM staging system for non-small cell lung cancer with lobectomy in stage IA-IIIA.

Rang-Rang Wang, Ming-Jun Li, Qiao Peng

|Feb 24, 2024
The prognosis of patients with primary pulmonary mucosa-associated lymphoid tissue lymphoma: Treated with surgery or chemotherapy?

Ye Ning, Haiyan He, Qiuyuan Li

|Feb 16, 2024
Is there a prognostic difference among stage I lung adenocarcinoma patients with different BRAF-mutation status?

Shang-Shang Ma, Rang-Rang Wang, Qiao Peng

|Nov 24, 2023
Prognostic outcomes and recurrence patterns in resected stage I lung adenocarcinoma harbouring atypical epidermal growth factor receptor mutations.

Tao Chen, Jialiang Wen, Yingze Li

Pageof 3

Frequent Collaborators

8 joint publications

Leilei Wu

6 joint publications

Jiayi Qian

4 joint publications

Zhi-Xin Li

2 joint publications

Yu'e Liu